- Home
- ZLAB vs STAA Comparison
ZLAB vs STAA Comparison
Compare ZLAB & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | STAA |
|---|---|---|
| Founded | 2013 | 1982 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.2B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZLAB | STAA |
|---|---|---|
| Price | $18.19 | $22.52 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 10 |
| Target Price | ★ $57.22 | $24.56 |
| AVG Volume (30 Days) | 847.8K | ★ 1.6M |
| Earning Date | 02-26-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $441,629,000.00 | $230,591,000.00 |
| Revenue This Year | $26.16 | N/A |
| Revenue Next Year | $30.62 | $21.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.14 | N/A |
| 52 Week Low | $16.82 | $13.50 |
| 52 Week High | $44.34 | $30.81 |
Technical Indicators
Market Signals| Indicator | ZLAB | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 37.98 |
| Support Level | $17.18 | $22.97 |
| Resistance Level | $17.97 | $24.26 |
| Average True Range (ATR) | 0.60 | 1.19 |
| MACD | 0.28 | -0.08 |
| Stochastic Oscillator | 64.84 | 36.48 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.